Kinetics of hepatic bile acid handling in cholestatic liver disease: effect of ursodeoxycholic acid. (Q51597193)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8276175%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

title

Kinetics of hepatic bile acid handling in cholestatic liver disease: effect of ursodeoxycholic acid (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8276175%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference

R P Jazrawi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8276175%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

J S de Caestecker

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8276175%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

P M Goggin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8276175%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

A J Britten

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8276175%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

A E Joseph

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8276175%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

J D Maxwell

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8276175%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

T C Northfield

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8276175%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

language of work or name

English

0 references

publication date

1 January 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8276175%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8276175%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

volume

106

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8276175%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8276175%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

page(s)

134-142

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8276175%20AND%20SRC:MED&resulttype=core&format=json

Ursodeoxycholic acid for primary biliary cirrhosis

28 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2894%2994899-2

Update on primary biliary cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2894%2994899-2

Solubilization of lipids from hamster bile-canalicular and contiguous membranes and from human erythrocyte membranes by conjugated bile salts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2894%2994899-2

Direct measurement of first-pass ileal clearance of a bile acid in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2894%2994899-2

Technetium-99m-labelled diethyl-acetanilido-iminodiacetate: a new hepatobiliary agent. A preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2894%2994899-2

Radiopharmaceuticals for hepatobiliary imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2894%2994899-2

Hepatic handling of a synthetic gamma-labeled bile acid (75SeHCAT)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2894%2994899-2

Ursodeoxycholic acid in chronic liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2894%2994899-2

A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2894%2994899-2

Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2894%2994899-2

Ursodeoxycholic acid in primary biliary cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2894%2994899-2

Effect of ursodeoxycholic acid in chronic hepatitis and primary biliary cirrhosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2894%2994899-2

Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2894%2994899-2

Ursodeoxycholic acid for the treatment of primary biliary cirrhosis. Interim analysis of a double-blind multicentre randomized trial. The UDCA-PBC Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2894%2994899-2

Ursodeoxycholic acid for primary sclerosing cholangitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2894%2994899-2

Bile acid glycine and taurine conjugates in serum of patients with primary biliary cirrhosis: effect of ursodeoxycholic treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2894%2994899-2

Ursodeoxycholate reduces hepatotoxicity of bile salts in primary human hepatocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2894%2994899-2

Conjugates of ursodeoxycholate protect against cytotoxicity of more hydrophobic bile salts: in vitro studies in rat hepatocytes and human erythrocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2894%2994899-2

Difference in the effects of ursodeoxycholate and its taurine conjugate on the biliary excretion of sulfobromophthalein in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2894%2994899-2

Mechanism of ursodeoxycholic acid- and canrenoate-induced biliary bicarbonate secretion and the effect on glucose- and amino acid-induced cholestasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2894%2994899-2

Ursodeoxycholic acid-induced changes of plasma and urinary bile acids in patients with primary biliary cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2894%2994899-2

Assessment of activity in chronic active liver disease. Serum bile acids compared with conventional tests and histology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2894%2994899-2

Tauroursodeoxycholate prevents taurocholate induced cholestasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2894%2994899-2

Effects of ursodeoxycholic acid treatment on nutrition and liver function in patients with cystic fibrosis and longstanding cholestasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2894%2994899-2

Scintigraphic documentation of an improvement in hepatobiliary excretory function after treatment with ursodeoxycholic acid in patients with cystic fibrosis and associated liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2894%2994899-2

Effect of ursodeoxycholic acid administration on biliary lipid secretion in primary biliary cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2894%2994899-2

Effect of ursodeoxycholic acid on bile acid metabolism in primary biliary cirrhosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2894%2994899-2

Acute effects of ursodeoxycholic and chenodeoxycholic acid on the small intestinal absorption of bile acids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2894%2994899-2

Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2894%2994899-2

10.1016/S0016-5085(94)94899-2

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8276175%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference